Gamma Glutamyl Transferase as A Marker of Metabolic Syndrome
Nandini M S, Priya Santharam, Bindu D, Priya V
Journal of Angiotherapy 5(2) https://doi.org/10.25163/angiotherapy.52121602920201221
Submitted: 29 November 2021 Revised: 10 December 2021 Published: 20 December 2021
Abstract
In an era of a cardiovascular epidemic an imminent search has been sought for more sensitive and specific markers of sub-clinical inflammation, thermogenesis, and increased adiposity. This study attempts to assess how serum Gamma Glutamyl Transferase [GGT] performed as an ideal endogenous substance for the diagnosis of metabolic syndrome and hence estimate cardiovascular risk.
Keywords: Gamma Glutamyl Transferase, Hypothyroidism, Malignant diseases
References
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Costa, F. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, 112(17), 2735-2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
View Dimensions
View Altmetric
Save
Citation
View
Share